@article {2116, title = {Anti-Neoplastic and Cytotoxicity Potency Measuring of Five Medicago sativa L. (Alfalfa) Leaf Extracts Towards Melanoma (UACC62), Breast (MCF7), Prostate (PC3), and Colon (HCT116) Cancer Cells}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {October 2023}, pages = {768-776}, type = {Original Article}, chapter = {768}, abstract = {

The National Cancer Registry of the National Department of Health of South Africa confirms that in females, the highest incidence of cancers diagnosed in the year 2019 was breast (10 172 cases), cervical (6 945 cases) and colorectal (1 952 cases) cancers, while in males the most diagnosed cancers were prostate, lung, and colorectal neoplasms. The risk factors that promote cancer development, and metastasis or spreading includes excessive alcohol and narcotic usage, carcinogenic infections (oncoviruses) and genetical predispositions. The global incidence of cancer is much likely to increase because of the increased exposure to risk factors (processed fast foods, industrial toxins in air and water) that promote oxidative stress, low grade chronic inflammation, diabetes mellitus, hyperglycemia, and insulin resistance. Because the ancient healer or doctor relied on plants and other natural resources for therapeutic compounds, we wanted to measure the anti-cancer actions induced by our Alfac-facah leaf extracts towards four major cancer cells. The growth inhibitory and cytotoxicity activity that was induced by our extracts was measured using the reliable Sulforhodamine B Assay as per the collaborative research program between the CSIR{\textquoteright}s Biosciences Pharmacology Group and the NCI. Our Alfac-facah leaf test material was extracted using five solvents: Ethanol, Methanol, Diethyl-ether, Acetone, and Water. Medicinal Plants persist to play a key role in medicine, whereby they not only help with treating or preventing diseases, but they also contribute to the general wellbeing of the patient. For this reason, natural resources remain a pivotal ingredient of novel drug development compounds

}, keywords = {AICR (American Institute for Cancer Research), Cancer (malignancy, Carcinoma, CSIR (The Council for Scientific and Industrial Research, ECACC (European Collection of Authenticated Cell Cultures, International Agency for Research on Cancer (IARC), Leukemia, lymphoma), Medicago sativa L. (Alfalfa), NCI (National Cancer Institute, neoplasm, sarcoma, South Africa), Sulforhodamine B Assay (SRB), THC (delta-9 tetrahydrocannabinol). Rick Simpson oil (RSO)., Tumour, U.S Department of Health and Human Services), UK)}, doi = {10.5530/pj.2023.15.150}, author = {Makhele Thapelo Simon and Makhoahle Pakiso Moses and Mashele Sitheni Samson} } @article {1915, title = {Prostate Cancer: Causes and Medicinal Plants Used in Africa for Twenty Years (2001-2021)}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {December 2022}, pages = {822-828}, type = {Research Article }, chapter = {822}, abstract = {

Prostate cancer is one of deadliest cancers in the universe especially in Africa. A lot of work has been done on the treatment and control of breast cancer, colon/colorectal cancer, skin cancer, etc. Only a few works on prostate cancer has been published in literature. The conventional method of treatment used is almost not affordable by many cancer patients due to high cost of drugs and therapy. Also, the cumulative side effects arising from the treatment is enormous to patients. Hence, there is need to exploit local herbs that contain active anticancer ingredients that are readily available and affordable with little or no side effects. The present review was carried out to evaluate published works on medicinal plant species used for treatment and control of prostate cancer in Africa for twenty years (2001-2021). A total number of 48 plant species with 40 families were retrieved from database using ScienceDirect, Google scholar, Web of Science, Springerlink, Scopus, PubMed, and BioMed. All the plant species were reported to possess cytotoxic activity against prostate cancer cell lines in vitro and in vivo. The most cited plant species according to literature sources are Hypoxis hemerocallidea, Plumbago zeylanica, Gongronema latifolium and Mangifera indica. Plant families that were used more in treating prostate cancer were Apocynaceae, Fabaceae, Asteraceae, Cucurbitaceae, Bignoniaceae, Lamiaceae. We conclude that more research be carried out on the medicinal plants{\textquoteright} usage on the treatment of prostate cancer and further bio-prospecting drugs from the enlisted plants should explored by the pharmaceuticals in Africa.

}, keywords = {Cure, Death, Ethnobotany, Families, Phytomedicine, Tumour}, doi = {10.5530/pj.2022.14.174}, author = {Oludare Oladipo Agboola and Samuel Bawa Ijimbili and Gift Onyinyechukwu Ofuasia and Joseph Anejo-Okopi and Jasini Alexander Wahedi and Joshua Oluwole Olowoyo} }